AJTMH Tropical Medicine and Hygiene News
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am. J. Trop. Med. Hyg., 64(5), 2001, pp. 229-232
Copyright © 2001 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moyou-Somo, R
Right arrow Articles by Guemkam, G
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moyou-Somo, R
Right arrow Articles by Guemkam, G
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*QUININE
Related Collections
Right arrow Travel Medicine
Right arrow Health Outcomes
Right arrow Malaria
American Journal of Tropical Medicine and Hygiene, Vol 64, Issue 5, 229-232
Copyright © 2001 by American Society of Tropical Medicine and Hygiene

Research Articles


Clinical trial of beta-arteether versus quinine for the treatment of cerebral malaria in children in Yaounde, Cameroon

R Moyou-Somo, F Tietche, M Ondoa, LE Kouemeni, T Ekoe, E Mbonda, C Nsangou, B Jemea, and G Guemkam

One hundred and two children aged 0-10 years with cerebral malaria (Blantyre coma score of 2 or less) were randomly treated either with intramuscular arteether (3.2 mg/kg on Day 0, followed by 1.6 mg/kg on Days 1 to 4) or intravenous (i.v.) quinine dihydrochloride (20 mg of the salt/kg, followed by 10 mg of the salt/kg every 8 hr up to Day 6). Treatment with oral quinine sulfate (10 mg/kg every 8 hr) was substituted for i.v. quinine when the patient was able to take oral medicine. All patients were followed up in the hospital for 7 days; thereafter, they were treated as outpatients on Days 14, 21, and 28. Mortality rate, the main efficacy parameter, was 11.8% lower in the arteether treatment group than in the quinine group (15.7% versus 27.4%); however, the difference was not significant (P = 0.25). Means for fever clearance time, coma resolution time, and parasite clearance time were similar in the 2 treatment groups (42.2 +/- 34.9 hr; 34.8 +/- 18.8 hr, and 46.3 +/- 28.5 hr, respectively for arteether, versus 45.0 +/- 26.7 hr; 30.3 +/- 18.9 hr, and 40.7 +/- 18.9 hr, respectively, for quinine). At 28 days, the cure rates were 73.2% and 64.9% for the arteether and quinine treatment groups, respectively. Arteether is safe and therapeutically at least as effective as quinine for the treatment of cerebral malaria in children in Cameroon. Because of its ease of administration, arteether appears to be suited for use in the rural zones where monitoring facilities do not exist.


This article has been cited by other articles:


Home page
Am J Trop Med HygHome page
A. PAREEK, A. NANDY, D. KOCHAR, K. H. PATEL, S. K. MISHRA, and P. C. MATHUR
EFFICACY AND SAFETY OF {beta}-ARTEETHER AND {alpha}/{beta}-ARTEETHER FOR TREATMENT OF ACUTE PLASMODIUM FALCIPARUM MALARIA.
Am J Trop Med Hyg, July 1, 2006; 75(1): 139 - 142.
[Abstract] [Full Text] [PDF]


Home page
Am J Trop Med HygHome page
Q. LI, C. B. LUGT, S. LOOAREESUWAN, S. KRUDSOOD, P. WILAIRATANA, S. VANNAPHAN, K. CHALEARMRULT, and W. K. MILHOUS
PHARMACOKINETIC INVESTIGATION ON THE THERAPEUTIC POTENTIAL OF ARTEMOTIL ({beta}-ARTEETHER) IN THAI PATIENTS WITH SEVERE PLASMODIUM FALCIPARUM MALARIA
Am J Trop Med Hyg, December 1, 2004; 71(6): 723 - 731.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American Society of Tropical Medicine and Hygiene.